Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phytanoyl-CoA 2-hydroxylase interacting protein (PHYHIP) is a cytoplasmic protein encoded by the PHYHIP gene on chromosome 8 in humans. It interacts with phytanoyl-CoA 2-hydroxylase (PHYH/PAHX) and is thought to play a role in the development of the central nervous system, although its precise molecular function remains incompletely characterized. PHYHIP displays protein tyrosine kinase binding activity and is involved in protein localization. While PHYHIP is associated by gene proximity with Refsum disease, it is not itself a classic therapeutic target and currently has no known drugs or targeted biomarkers. There is no evidence for PHYHIP functioning as a receptor, enzyme, transporter, or transcription factor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phytanoyl-CoA 2-hydroxylase interacting protein (PHYHIP).